Pecto-intercostal fascial block vs Pecc block
Not Applicable
Completed
- Conditions
- CancerSurgerypostoperative pain after unilateral modified radical mastectomy
- Registration Number
- PACTR201709002647413
- Lead Sponsor
- Tanta University, Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
aged between 30 and 70 years; ASA I-III, undergoing unilateral MRM
Exclusion Criteria
body mass index (BMI > 35kg/m2; Mental disorders; any contraindication to regional anesthesia (eg local infection, coagulation abnormality or patient refusal); known allergy to study drugs; pregnancy; drug or alchol abuse; daily intake of opioid analgesics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of pecto-intercostal fascial block in post-mastectomy pain management?
How does the pecto-intercostal fascial block compare to standard multimodal analgesia in postoperative pain control after modified radical mastectomy?
Are there specific biomarkers that predict optimal response to pectoral nerve block combinations in breast cancer surgery patients?
What adverse events are associated with pecto-intercostal fascial block techniques and how are they managed in postoperative care?
What combination analgesic strategies show promise for post-mastectomy pain alongside regional nerve blocks?